HI
PFE icon

Hendershot Investments’s Pfizer PFE Stock Holding History

Hendershot Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$562K Sell
20,005
-907
-4% -$24.1K 0.08% 80
2025
Q4 		$521K Sell
20,912
-255
-1% -$6.43K 0.07% 80
2025
Q3 		$539K Sell
21,167
-1,795
-8% -$44.3K 0.07% 82
2025
Q2 		$557K Sell
22,962
-1,563
-6% -$36.5K 0.07% 81
2025
Q1 		$621K Buy
24,525
+414
+2% +$10.8K 0.08% 79
2024
Q4 		$640K Sell
24,111
-784
-3% -$21.3K 0.09% 75
2024
Q3 		$720K Buy
24,895
+2,798
+13% +$81.6K 0.1% 73
2024
Q2 		$618K Sell
22,097
-14,065
-39% -$387K 0.09% 77
2024
Q1 		$1M Sell
36,162
-4,287
-11% -$119K 0.14% 59
2023
Q4 		$1.16M Sell
40,449
-1,150
-3% -$34.8K 0.18% 58
2023
Q3 		$1.38M Sell
41,599
-117
-0.3% -$4.14K 0.23% 53
2023
Q2 		$1.53M Sell
41,716
-375
-0.9% -$14.6K 0.25% 51
2023
Q1 		$1.72M Sell
42,091
-2,170
-5% -$93.7K 0.29% 52
2022
Q4 		$2.27M Sell
44,261
-175
-0.4% -$8.39K 0.38% 48
2022
Q3 		$1.95M Hold
44,436
– – 0.37% 53
2022
Q2 		$2.33M Sell
44,436
-213
-0.5% -$10.9K 0.41% 53
2022
Q1 		$2.31M Hold
44,649
– – 0.35% 57
2021
Q4 		$2.64M Buy
44,649
+27,835
+166% +$1.38M 0.4% 55
2021
Q3 		$723K Buy
16,814
+6,100
+57% +$270K 0.14% 60
2021
Q2 		$420K Hold
10,714
– – 0.09% 63
2021
Q1 		$388K Hold
10,714
– – 0.09% 63
2020
Q4 		$394K Buy
10,714
+148
+1% +$5.43K 0.1% 62
2020
Q3 		$368K Sell
10,566
-369
-3% -$12.9K 0.1% 58
2020
Q2 		$339K Buy
10,935
+610
+6% +$20.7K 0.11% 54
2020
Q1 		$320K Hold
10,325
– – 0.12% 53
2019
Q4 		$384K Buy
10,325
+3,072
+42% +$109K 0.11% 57
2019
Q3 		$247K Hold
7,253
– – 0.08% 66
2019
Q2 		$298K Buy
7,253
+2,220
+44% +$88.2K 0.1% 61
2019
Q1 		$203K Buy
5,033
+240
+5% +$9.61K 0.07% 71
2018
Q4 		$198K Sell
4,793
-238
-5% -$9.88K 0.08% 61
2018
Q3 		$210K Buy
+5,031
New +$194K 0.07% 65

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hendershot Investments's PFE Position: Q1 2026 in Review

Hendershot Investments reduced its Pfizer (PFE) stake by 4.3% in Q1 2026, selling an estimated $24.1K and leaving 20,005 shares worth $562K. The position accounts for 0.08% of the portfolio, ranked #80.

Hendershot Investments first reported a position in PFE in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.64M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hendershot Investments held 20,005 shares of Pfizer worth $562K as of Q1 2026.
  • Hendershot Investments sold 907 Pfizer shares in Q1 2026, an estimated $24.1K.
  • Pfizer made up 0.08% of Hendershot Investments's portfolio in Q1 2026, its #80 holding.
  • Hendershot Investments first reported a position in Pfizer in Q3 2018 and has held it in 31 quarters since.
  • Hendershot Investments's Pfizer position peaked at $2.64M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hendershot Investments's 13F filing for Q1 2026, filed 27 Apr 2026.